ChinaDaily Briefs

Daily Brief China: Oriental Watch, Dickson Concepts Intl, InSilico Medicine Cayman TopCo, Longfor Properties and more

In today’s briefing:

  • An Update on Oriental Watch (398 HK)
  • Dickson Concepts: Gleanings From the FY23 Annual Report
  • Pre-IPO InSilico Medicine – AI Pharmaceutical Is Immature; Valuation Expansion Relies on Imagination
  • Morning Views Asia: Anton Oilfield, Central China Securities


An Update on Oriental Watch (398 HK)

By Oriental Value

  • A Review on Final Results Oriental Watch recently announced its earnings for the fiscal year, and the results were quite impressive.
  • On June 20, 2023, the company reported a revenue of HKD3.7 billion and a net profit of HKD295 million.
  • These figures surpassed our initial estimates of HKD3.

Dickson Concepts: Gleanings From the FY23 Annual Report

By Sameer Taneja

  • In my previous insight Dickson Concepts 113 HK: Straight From The Ben Graham Stable, >40% Discount to NCAV, I highlighted why one must explore the stock as a viable investment.
  • NCAV (Net current asset value) in FY23 was 7.5 HKD/share ( Vs. current share price of 4.25 HKD/share), with net cash + ST/LT financial investments now at 9.7 HKD/share. 
  • Absolute DPS ( dividend per share) was 35 cents representing a yield of 8.2% ( payout ratio of 55%). The trailing PE is 6.6x FY23. 

Pre-IPO InSilico Medicine – AI Pharmaceutical Is Immature; Valuation Expansion Relies on Imagination

By Xinyao (Criss) Wang

  • InSilico ’s business model is more of AI-CXO + AI-SaaS, but hasn’t reached the stage of AI-biotech, considering its current revenue streams, which may lead to InSilico ultimately changing its positioning.
  • The significance of pipeline lies in the need for InSilico to verify the effectiveness of AI platforms/algorithms/technology through successful product launch. However, valuation of InSilico could be different from biotech.
  • AI pharmaceutical industry is at its infancy, which is a far cry from current levels of investment and expectations in the sector.We advise investors to be rational about this field.

Morning Views Asia: Anton Oilfield, Central China Securities

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars